Pemphigus Foliaceus Latest Advances

From Empiricism to Precision: Century of Paradigm Shifts in Medical Dermatology.

Journal: Clinics in dermatology

Published: October 13, 2026

BCMA-Targeted T-Cell Engager Therapy for Refractory Pemphigus.

Journal: JAMA dermatology

Published: September 30, 2026

Successful treatment of recalcitrant pemphigus vulgaris with cold argon plasma.

Journal: Acta dermatovenerologica Alpina, Pannonica, et Adriatica

Published: September 27, 2026

Beyond Desmoglein Compensation: Interpreting Clinicopathologic Discordance in Pemphigus.

Journal: International journal of dermatology

Published: September 25, 2026

Correction to "Incidence Trends and Severe in-Hospital Outcomes of Pemphigus Vulgaris: A Nationwide Cohort Study".

Journal: The Journal of dermatology

Published: September 22, 2026

Clinical-pharmacodynamic discordance in pemphigus: beyond conventional anti-desmoglein ELISA.

Journal: The British journal of dermatology

Published: September 18, 2026

Methodological and reporting concerns regarding anti-rituximab antibodies in pemphigus.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: September 17, 2026

Clinical Characteristics and Surgical Outcomes of Retroperitoneal Unicentric Castleman Disease: A Single-Center Retrospective Study.

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: September 16, 2026

Bruton Tyrosine Kinase Inhibitors in Immune-Mediated Skin Diseases: Current Evidence and Future Directions.

Journal: International journal of molecular sciences

Published: September 15, 2026

Mucosal-First Pemphigus Vulgaris With Delayed Generalized Bullous Eruption: A Case Report.

Journal: Case reports in dermatological medicine

Published: September 10, 2026

Hypogammaglobulinemia and Infection After Rituximab in Pemphigus, With Divergent Desmoglein Antibody and Immunoglobulin Kinetics: A Retrospective Cohort Study.

Pemphigus Foliaceus Latest Advances

Find the Latest Research About Pemphigus Foliaceus

From Empiricism to Precision: Century of Paradigm Shifts in Medical Dermatology.

From Empiricism to Precision: Century of Paradigm Shifts in Medical Dermatology.

BCMA-Targeted T-Cell Engager Therapy for Refractory Pemphigus.

BCMA-Targeted T-Cell Engager Therapy for Refractory Pemphigus.

Successful treatment of recalcitrant pemphigus vulgaris with cold argon plasma.

Successful treatment of recalcitrant pemphigus vulgaris with cold argon plasma.

Beyond Desmoglein Compensation: Interpreting Clinicopathologic Discordance in Pemphigus.

Beyond Desmoglein Compensation: Interpreting Clinicopathologic Discordance in Pemphigus.

Correction to "Incidence Trends and Severe in-Hospital Outcomes of Pemphigus Vulgaris: A Nationwide Cohort Study".

Correction to "Incidence Trends and Severe in-Hospital Outcomes of Pemphigus Vulgaris: A Nationwide Cohort Study".

Clinical-pharmacodynamic discordance in pemphigus: beyond conventional anti-desmoglein ELISA.

Clinical-pharmacodynamic discordance in pemphigus: beyond conventional anti-desmoglein ELISA.

Methodological and reporting concerns regarding anti-rituximab antibodies in pemphigus.

Methodological and reporting concerns regarding anti-rituximab antibodies in pemphigus.

Clinical Characteristics and Surgical Outcomes of Retroperitoneal Unicentric Castleman Disease: A Single-Center Retrospective Study.

Clinical Characteristics and Surgical Outcomes of Retroperitoneal Unicentric Castleman Disease: A Single-Center Retrospective Study.

Bruton Tyrosine Kinase Inhibitors in Immune-Mediated Skin Diseases: Current Evidence and Future Directions.

Bruton Tyrosine Kinase Inhibitors in Immune-Mediated Skin Diseases: Current Evidence and Future Directions.

Mucosal-First Pemphigus Vulgaris With Delayed Generalized Bullous Eruption: A Case Report.

Mucosal-First Pemphigus Vulgaris With Delayed Generalized Bullous Eruption: A Case Report.

Hypogammaglobulinemia and Infection After Rituximab in Pemphigus, With Divergent Desmoglein Antibody and Immunoglobulin Kinetics: A Retrospective Cohort Study.

Hypogammaglobulinemia and Infection After Rituximab in Pemphigus, With Divergent Desmoglein Antibody and Immunoglobulin Kinetics: A Retrospective Cohort Study.

The transition of pemphigus vulgaris into pemphigus foliaceus: A case report.

The transition of pemphigus vulgaris into pemphigus foliaceus: A case report.